Safety of TKI258 in Advanced/Metastatic Melanoma Subjects
Condition(s):MelanomaLast Updated:March 11, 2021Completed
Hide Studies Not Open or Pending
Condition(s):MelanomaLast Updated:March 11, 2021Completed
Condition(s):Lung CancerLast Updated:December 23, 2020Completed
Condition(s):Lung Adenocarcinoma; EGFR Positive Non-small Cell Lung CancerLast Updated:June 2, 2016Unknown status
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:December 19, 2020Completed
Condition(s):Gastrointestinal Stromal TumorsLast Updated:January 18, 2020Completed
Condition(s):Tyrosine Kinase Inhibitors; Chronic Myeloid LeukemiaLast Updated:March 20, 2024Recruiting
Condition(s):Non-Small Cell Adenocarcinoma; Tyrosine Kinase Mutation; EGFR Gene MutationLast Updated:March 7, 2017Unknown status
Condition(s):Adenoid Cystic CarcinomaLast Updated:November 13, 2014Completed
Condition(s):Adenoid Cystic CarcinomaLast Updated:November 9, 2018Completed
Condition(s):Non-small Cell Lung Cancer; EGFR Gene Mutation; EGFR-TKI Resistant MutationLast Updated:October 6, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.